NanoGroup S.A. (WSE:NNG)

Market Cap	83.63M
Revenue (ttm)	-6.90K
Net Income (ttm)	-6.93M
Shares Out	32.16M
EPS (ttm)	-0.19
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	48,811
Average Volume	55,127
Open	2.620
Previous Close	2.620
Day's Range	2.565 - 2.630
52-Week Range	2.250 - 3.830
Beta	0.70
RSI	43.26
Earnings Date	Nov 28, 2025

About NanoGroup

NanoGroup S.A. operates as a biotechnology company in Poland. The company develops and licenses early-stage pre-clinical and IND solutions to international biotech and pharma companies. It also manages a portfolio of companies that manages projects for the need of modern medicine in the field of oncology and transplantology. The company was incorporated in 2016 and is based in Warsaw, Poland.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2016
• Country: Poland
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: NNG

Financial Performance

In 2024, NanoGroup's revenue was 2,100, an increase of 4.01% compared to the previous year's 2,019. Losses were -5.17 million, -34.50% less than in 2023.